| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 60 |
| 1 | LENALIDOMIDE | 49 |
| 2 | METHOTREXATE | 47 |
| 3 | LEVONORGESTREL | 38 |
| 4 | CYCLOPHOSPHAMIDE | 34 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 34 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 34 |
| 7 | DOXORUBICIN | 34 |
| 8 | METFORMIN | 34 |
| 9 | METFORMIN ER 500 MG | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IRON, FOLIC ACID, CYANOCOBALAMIN, ASCORBIC ACID, AND DOCUSATE SODIUM | 1 | 0.0455 |
| 1 | TOREMIFENE CITRATE | 5 | 0.0116 |
| 2 | SETMELANOTIDE | 1 | 0.0035 |
| 3 | L-ARGININE | 1 | 0.0028 |
| 4 | METEX | 1 | 0.0026 |
| 5 | DROSPIRENONE AND ESTRADIOL | 1 | 0.0019 |
| 6 | OSPEMIFENE | 4 | 0.0015 |
| 7 | BARICITINIB | 4 | 0.0013 |
| 8 | MECASERMIN | 1 | 0.0012 |
| 9 | ISATUXIMAB | 7 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 94 |
| 1 | Thalidomide Analog [EPC] | 49 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 47 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 46 |
| 4 | Alkylating Drug [EPC] | 39 |
| 5 | Progestin [EPC] | 39 |
| 6 | Progestin-containing Intrauterine System [EPC] | 38 |
| 7 | Platinum-based Drug [EPC] | 37 |
| 8 | Aromatase Inhibitor [EPC] | 35 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Estrogen Agonist/Antagonist [EPC] | 4 | 0.0015 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 3 | Androgen [EPC] | 28 | 0.0010 |
| 4 | Gonadotropin [EPC] | 1 | 0.0005 |
| 5 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 6 | Progesterone [EPC] | 8 | 0.0003 |
| 7 | Aromatase Inhibitor [EPC] | 35 | 0.0003 |
| 8 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 3 | 0.0002 |
| 9 | Progestin Antagonist [EPC] | 1 | 0.0002 |